Steve Jensen Joins The Weinberg Group (now ProPharma Group)

February 3, 2015

The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings.
"Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide."
Steve Jensen

Senior Vice President, Head of Regulatory Consulting

+1 706.286.8841 direct

+1 706.371.8206 mobile

TAGS:

July 31, 2018

ProPharma Group Announces New Medical Information Contact Center

ProPharma Group today announces the opening of a new medical information contact center in Fort Washington, Pennsylvania to accommodate our growing business. ProPharma Group, a provider of...

April 24, 2018

ProPharma Group Announces New President / CEO

ProPharma Group announced today that Dawn Sherman has been named President and CEO, effective May 14, 2018. A veteran in leading healthcare-focused businesses, Dawn brings extensive international...

April 11, 2012

ProPharma Group, Inc. announces the opening of a new office in Southern California

Overland Park, Kansas – Carlsbad, California ProPharma Group is pleased to announce the opening of a new office in Carlsbad, California. This is another significant step for ProPharma Group and its'...